IL
Illinois House Bill HB3873

Illinois 2023-2024 Regular Session

Illinois House Bill HB3873 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED: 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance. LRB103 31050 RLC 57668 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED: 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance. LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b A BILL FOR
22 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED:
33 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
44 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
55 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance.
66 LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b
77 LRB103 31050 RLC 57668 b
88 A BILL FOR
99 HB3873LRB103 31050 RLC 57668 b HB3873 LRB103 31050 RLC 57668 b
1010 HB3873 LRB103 31050 RLC 57668 b
1111 1 AN ACT concerning criminal law.
1212 2 Be it enacted by the People of the State of Illinois,
1313 3 represented in the General Assembly:
1414 4 Section 5. The Illinois Controlled Substances Act is
1515 5 amended by changing Section 206 as follows:
1616 6 (720 ILCS 570/206) (from Ch. 56 1/2, par. 1206)
1717 7 Sec. 206. (a) The controlled substances listed in this
1818 8 Section are included in Schedule II.
1919 9 (b) Unless specifically excepted or unless listed in
2020 10 another schedule, any of the following substances whether
2121 11 produced directly or indirectly by extraction from substances
2222 12 of vegetable origin, or independently by means of chemical
2323 13 synthesis, or by combination of extraction and chemical
2424 14 synthesis:
2525 15 (1) Opium and opiates, and any salt, compound,
2626 16 derivative or preparation of opium or opiate, excluding
2727 17 apomorphine, dextrorphan, levopropoxyphene, nalbuphine,
2828 18 nalmefene, naloxone, and naltrexone, and their respective
2929 19 salts, but including the following:
3030 20 (i) Raw Opium;
3131 21 (ii) Opium extracts;
3232 22 (iii) Opium fluid extracts;
3333 23 (iv) Powdered opium;
3434
3535
3636
3737 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED:
3838 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
3939 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
4040 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance.
4141 LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b
4242 LRB103 31050 RLC 57668 b
4343 A BILL FOR
4444
4545
4646
4747
4848
4949 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
5050
5151
5252
5353 LRB103 31050 RLC 57668 b
5454
5555
5656
5757
5858
5959
6060
6161
6262
6363 HB3873 LRB103 31050 RLC 57668 b
6464
6565
6666 HB3873- 2 -LRB103 31050 RLC 57668 b HB3873 - 2 - LRB103 31050 RLC 57668 b
6767 HB3873 - 2 - LRB103 31050 RLC 57668 b
6868 1 (v) Granulated opium;
6969 2 (vi) Tincture of opium;
7070 3 (vii) Codeine;
7171 4 (viii) Ethylmorphine;
7272 5 (ix) Etorphine Hydrochloride;
7373 6 (x) Hydrocodone;
7474 7 (xi) Hydromorphone;
7575 8 (xii) Metopon;
7676 9 (xiii) Morphine;
7777 10 (xiii.5) 6-Monoacetylmorphine;
7878 11 (xiv) Oxycodone;
7979 12 (xv) Oxymorphone;
8080 13 (xv.5) Tapentadol;
8181 14 (xvi) Thebaine;
8282 15 (xvii) Thebaine-derived butorphanol.
8383 16 (xviii) Methorphan, except drug products
8484 17 containing dextromethorphan that may be dispensed
8585 18 pursuant to a prescription order of a practitioner and
8686 19 are sold in compliance with the safety and labeling
8787 20 standards as set forth by the United States Food and
8888 21 Drug Administration, or drug products containing
8989 22 dextromethorphan that are sold in solid, tablet,
9090 23 liquid, capsule, powder, thin film, or gel form and
9191 24 which are formulated, packaged, and sold in dosages
9292 25 and concentrations for use as an over-the-counter drug
9393 26 product. For the purposes of this Section,
9494
9595
9696
9797
9898
9999 HB3873 - 2 - LRB103 31050 RLC 57668 b
100100
101101
102102 HB3873- 3 -LRB103 31050 RLC 57668 b HB3873 - 3 - LRB103 31050 RLC 57668 b
103103 HB3873 - 3 - LRB103 31050 RLC 57668 b
104104 1 "over-the-counter drug product" means a drug that is
105105 2 available to consumers without a prescription and sold
106106 3 in compliance with the safety and labeling standards
107107 4 as set forth by the United States Food and Drug
108108 5 Administration.
109109 6 (2) Any salt, compound, isomer, derivative or
110110 7 preparation thereof which is chemically equivalent or
111111 8 identical with any of the substances referred to in
112112 9 subparagraph (1), but not including the isoquinoline
113113 10 alkaloids of opium;
114114 11 (3) Opium poppy and poppy straw;
115115 12 (4) Coca leaves and any salt, compound, isomer, salt
116116 13 of an isomer, derivative, or preparation of coca leaves
117117 14 including cocaine or ecgonine, and any salt, compound,
118118 15 isomer, derivative, or preparation thereof which is
119119 16 chemically equivalent or identical with any of these
120120 17 substances, but not including decocainized coca leaves or
121121 18 extractions of coca leaves which do not contain cocaine or
122122 19 ecgonine (for the purpose of this paragraph, the term
123123 20 "isomer" includes optical, positional and geometric
124124 21 isomers);
125125 22 (5) Concentrate of poppy straw (the crude extract of
126126 23 poppy straw in either liquid, solid or powder form which
127127 24 contains the phenanthrine alkaloids of the opium poppy).
128128 25 (c) Unless specifically excepted or unless listed in
129129 26 another schedule any of the following opiates, including their
130130
131131
132132
133133
134134
135135 HB3873 - 3 - LRB103 31050 RLC 57668 b
136136
137137
138138 HB3873- 4 -LRB103 31050 RLC 57668 b HB3873 - 4 - LRB103 31050 RLC 57668 b
139139 HB3873 - 4 - LRB103 31050 RLC 57668 b
140140 1 isomers, esters, ethers, salts, and salts of isomers, whenever
141141 2 the existence of these isomers, esters, ethers and salts is
142142 3 possible within the specific chemical designation, dextrorphan
143143 4 excepted:
144144 5 (1) Alfentanil;
145145 6 (1.1) Carfentanil;
146146 7 (1.2) Thiafentanyl;
147147 8 (2) Alphaprodine;
148148 9 (3) Anileridine;
149149 10 (4) Bezitramide;
150150 11 (5) Bulk Dextropropoxyphene (non-dosage forms);
151151 12 (6) Dihydrocodeine;
152152 13 (7) Diphenoxylate;
153153 14 (8) Fentanyl;
154154 15 (8.5) Xylazine: (N-2,6-dimethylpheny1)-5,6-
155155 16 dihydro-4H-1,3 thiazin-2-amine), including its isomers,
156156 17 esters, ethers, salts, and salts of isomers, esters, and
157157 18 ethers, whenever the existence of such isomers, esters,
158158 19 ethers, and salts is possible within the specific chemical
159159 20 designation;
160160 21 (9) Sufentanil;
161161 22 (9.5) Remifentanil;
162162 23 (10) Isomethadone;
163163 24 (11) (Blank);
164164 25 (12) Levorphanol (Levorphan);
165165 26 (13) Metazocine;
166166
167167
168168
169169
170170
171171 HB3873 - 4 - LRB103 31050 RLC 57668 b
172172
173173
174174 HB3873- 5 -LRB103 31050 RLC 57668 b HB3873 - 5 - LRB103 31050 RLC 57668 b
175175 HB3873 - 5 - LRB103 31050 RLC 57668 b
176176 1 (14) Methadone;
177177 2 (15) Methadone-Intermediate,
178178 3 4-cyano-2-dimethylamino-4,4-diphenyl-1-butane;
179179 4 (16) Moramide-Intermediate,
180180 5 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic
181181 6 acid;
182182 7 (17) Pethidine (meperidine);
183183 8 (18) Pethidine-Intermediate-A,
184184 9 4-cyano-1-methyl-4-phenylpiperidine;
185185 10 (19) Pethidine-Intermediate-B,
186186 11 ethyl-4-phenylpiperidine-4-carboxylate;
187187 12 (20) Pethidine-Intermediate-C,
188188 13 1-methyl-4-phenylpiperidine-4-carboxylic acid;
189189 14 (21) Phenazocine;
190190 15 (22) Piminodine;
191191 16 (23) Racemethorphan;
192192 17 (24) (Blank);
193193 18 (25) Levo-alphacetylmethadol (some other names:
194194 19 levo-alpha-acetylmethadol, levomethadyl acetate, LAAM).
195195 20 (d) Unless specifically excepted or unless listed in
196196 21 another schedule, any material, compound, mixture, or
197197 22 preparation which contains any quantity of the following
198198 23 substances having a stimulant effect on the central nervous
199199 24 system:
200200 25 (1) Amphetamine, its salts, optical isomers, and salts
201201 26 of its optical isomers;
202202
203203
204204
205205
206206
207207 HB3873 - 5 - LRB103 31050 RLC 57668 b
208208
209209
210210 HB3873- 6 -LRB103 31050 RLC 57668 b HB3873 - 6 - LRB103 31050 RLC 57668 b
211211 HB3873 - 6 - LRB103 31050 RLC 57668 b
212212 1 (2) Methamphetamine, its salts, isomers, and salts of
213213 2 its isomers;
214214 3 (3) Phenmetrazine and its salts;
215215 4 (4) Methylphenidate;
216216 5 (5) Lisdexamfetamine.
217217 6 (e) Unless specifically excepted or unless listed in
218218 7 another schedule, any material, compound, mixture, or
219219 8 preparation which contains any quantity of the following
220220 9 substances having a depressant effect on the central nervous
221221 10 system, including its salts, isomers, and salts of isomers
222222 11 whenever the existence of such salts, isomers, and salts of
223223 12 isomers is possible within the specific chemical designation:
224224 13 (1) Amobarbital;
225225 14 (2) Secobarbital;
226226 15 (3) Pentobarbital;
227227 16 (4) Pentazocine;
228228 17 (5) Phencyclidine;
229229 18 (6) Gluthethimide;
230230 19 (7) (Blank).
231231 20 (f) Unless specifically excepted or unless listed in
232232 21 another schedule, any material, compound, mixture, or
233233 22 preparation which contains any quantity of the following
234234 23 substances:
235235 24 (1) Immediate precursor to amphetamine and
236236 25 methamphetamine:
237237 26 (i) Phenylacetone
238238
239239
240240
241241
242242
243243 HB3873 - 6 - LRB103 31050 RLC 57668 b
244244
245245
246246 HB3873- 7 -LRB103 31050 RLC 57668 b HB3873 - 7 - LRB103 31050 RLC 57668 b
247247 HB3873 - 7 - LRB103 31050 RLC 57668 b
248248 1 Some trade or other names: phenyl-2-propanone;
249249 2 P2P; benzyl methyl ketone; methyl benzyl ketone.
250250 3 (2) Immediate precursors to phencyclidine:
251251 4 (i) 1-phenylcyclohexylamine;
252252 5 (ii) 1-piperidinocyclohexanecarbonitrile (PCC).
253253 6 (3) Nabilone.
254254 7 (Source: P.A. 100-368, eff. 1-1-18.)
255255
256256
257257
258258
259259
260260 HB3873 - 7 - LRB103 31050 RLC 57668 b